Old Web
English
Sign In
Acemap
>
Paper
>
Agomelatine as a novel treatment option in panic disorder, results from an 8-week open-label trial.
Agomelatine as a novel treatment option in panic disorder, results from an 8-week open-label trial.
2015
K.M.L. Huijbregts
Neeltje M. Batelaan
J. Schonenberg
G. Veen
A.J.L.M. van Balkom
Keywords:
Panic disorder
Psychology
Clinical psychology
Psychiatry
Agomelatine
treatment options
open label
Psychotherapist
Correction
Source
Cite
Save
Machine Reading By IdeaReader
15
References
9
Citations
NaN
KQI
[]